NRD
GILD icon

Nebula Research & Development’s Gilead Sciences GILD Stock Holding History

Nebula Research & Development’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,738
Closed -$1.41M – 365
2025
Q2 		$1.41M Sell
12,738
-17,391
-58% -$1.85M 0.12% 281
2025
Q1 		$3.38M Buy
30,129
+27,009
+866% +$2.79M 0.31% 63
2024
Q4 		$288K Buy
+3,120
New +$281K 0.03% 719
2024
Q2 		– Sell
-4,167
Closed -$305K – 886
2024
Q1 		$305K Buy
+4,167
New +$320K 0.07% 524

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nebula Research & Development's GILD Position: Q3 2025 in Review

Nebula Research & Development sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 12,738 shares — an estimated $1.41M sold.

Nebula Research & Development first reported a position in GILD in Q1 2024 and held it in 4 quarters. The position peaked at $3.38M in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Nebula Research & Development reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 12,738 Gilead Sciences shares in Q3 2025, an estimated $1.41M.
  • Nebula Research & Development first reported a position in Gilead Sciences in Q1 2024 and held it in 4 quarters.
  • Nebula Research & Development's Gilead Sciences position peaked at $3.38M in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.